Compare OXBR & VVOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OXBR | VVOS |
|---|---|---|
| Founded | 2013 | 2016 |
| Country | Cayman Islands | United States |
| Employees | 4 | N/A |
| Industry | Property-Casualty Insurers | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.1M | 9.7M |
| IPO Year | N/A | 2020 |
| Metric | OXBR | VVOS |
|---|---|---|
| Price | $1.59 | $0.40 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $5.00 | $2.75 |
| AVG Volume (30 Days) | 58.8K | ★ 464.0K |
| Earning Date | 05-11-2026 | 04-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 6.76 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $17,443,000.00 |
| Revenue This Year | $80.09 | $69.66 |
| Revenue Next Year | $85.22 | $48.38 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 16.05 |
| 52 Week Low | $0.66 | $0.38 |
| 52 Week High | $2.85 | $5.95 |
| Indicator | OXBR | VVOS |
|---|---|---|
| Relative Strength Index (RSI) | 70.47 | 35.94 |
| Support Level | $1.51 | $0.38 |
| Resistance Level | $2.09 | $0.55 |
| Average True Range (ATR) | 0.17 | 0.05 |
| MACD | 0.03 | 0.00 |
| Stochastic Oscillator | 72.04 | 5.57 |
Oxbridge Re Holdings Ltd is a specialty property and casualty reinsurer that provides reinsurance solutions through its subsidiary. The company focuses on underwriting fully collateralized reinsurance contracts for property and casualty insurance companies in the Gulf Coast region of the United States, with an emphasis on Florida. It specializes in underwriting medium-frequency, high-severity risks where insufficient data exists to effectively analyze the risk/return profile of reinsurance contracts. The company generates revenue from three principal sources: premiums assumed from reinsurance on property and casualty business; income from investments, including unrealized gains or losses on other investments; and income from SurancePlus management fees.
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.